Skip to content

Pile Infrared-photocoagulation versus Ligation Exploratory Study Programme

Infrared photocoagulation versus rubber band ligation of first, second and third degree haemorrhoids in Jos University Teaching Hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201807152935140
Enrollment
58
Registered
2018-07-12
Start date
2018-06-10
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Surgery Haemorrhoids

Interventions

Infrared Photocoagulation

Sponsors

Dr Barnabas Alayande
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients with symptomatic Goligher grade I haemorrhoids (which do not prolapse) requiring treatment. 2. Adult patients with symptomatic Goligher grade II haemorrhoids (which prolapse during defaecation and reduce spontaneously) requiring treatment 3. Adult patients with symptomatic Goligher grade III haemorrhoids (which prolapse during defaecation and need to be manually reduced) requiring treatment.

Exclusion criteria

Exclusion criteria: 1. Patients presenting with Goligher Grade IV haemorrhoids, thrombosed haemorrhoids or infected haemorrhoids. 2. Patients with haemorrhoids associated with malignancy, inflammatory bowel disease or pregnancy. 3. Patients with associated anal fissures, anal spasm or infective anal pathologies like cryptitis or proctitis. 4. Patients with coagulation disorders as determined by clinical or laboratory parameters. 5. History of uncontrolled diabetes mellitus or other immunosuppressive illness. 6. Uncontrolled hypertension and other co-morbidities. 7. Patients who request for a particular modality of office treatment or surgery. 8. Patients who have had previous treatments beyond conservative measures including minimally invasive haemorrhoid treatments or haemorrhoidectomy. 9. Patients on oral flavinoid compounds or those applying micronised purified flavinoid derivatives locally to the anal region.

Design outcomes

Primary

MeasureTime frame
The resolution of all presenting symptoms and anatomical obliteration of the haemorrhoids.

Secondary

MeasureTime frame
The time to resumption of duties;Post procedure pain;early complication- bleeding;early complication-anal discharge;early complication- rectal tenesmus

Countries

Nigeria

Contacts

Public ContactBarnabas Alayande

Senior Registrar / Jos University Teaching Hospital

dr.alayande@gmail.com08035819290

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026